Acadia Pharmaceuticals | Ativos



Assets Alterar Data
Acadia Pharmaceuticals USD 1.23B 93.19M 2025-06
ALKERMES USD 2.25B 170.83M 2025-06
Alnylam Pharmaceuticals USD 4.57B 352.21M 2025-06
Biogen USD 28.33B 297.1M 2025-06
BioMarin Pharmaceutical USD 7.46B 309.33M 2025-06
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
Corcept Therapeutics USD 801.72M 44.73M 2025-06
Cytokinetics USD 1.23B 38.42M 2025-06
Eisai JPY 1.41T 23.07B 2025-06
Eli Lilly USD 100.92B 11.53B 2025-06
Incyte USD 5.82B 71.99M 2025-06
J&J USD 193.67B 13.57B 2025-03
Moderna USD 12.01B 694M 2025-06
Neurocrine Biosciences USD 3.89B 202.1M 2025-06
Pfizer USD 206.1B 1.93B 2025-06
Prothena USD 547.11M 48.15M 2024-12
PTC Therapeutics USD 2.63B 21.23M 2025-06
Sarepta Therapeutics USD 3.68B 214.43M 2025-06
Ultragenyx Pharmaceutical USD 1.31B 5.66M 2025-06
Vertex Pharmaceuticals USD 24.04B 1.16B 2025-06


Acadia Pharmaceuticals Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.